The article attempts to review the principal epidemiological data of the coronavirus
pandemic (COVID-19) based on the rapidly changing and expanding international and
domestic literature. The review covers the so-called ,,long COVID-19" as well as the
latest pharmacological and immunotherapeutic developments. The manuscript deals with
the future of innovative vaccinology, the so-called 'pan-vaccines' developed through
artificial intelligences and nano technology.
